Macrophages are an integral component of innate immunity and serve as the first line of defense against tissue damage and infection. Tissue-resident macrophages (TRMs) originate from embryonic precursor cells and differentiate into Microglia (brain), alveolar macrophages (lung), Kupffer cells (liver), Langerhans cells (skin), Lamina propria (intestine), red pulp/white pulp/marginal zonal (spleen), peritoneal macrophages (peritoneal cavity) (1). TRMs are seeded into the tissues and maintained throughout lifespan by local self-renewal. TRMs are highly specialized tissue-resident cells with diverse functions and play an important role in maintaining homeostasis by preventing infections, controlling inflammation, and regulating autoimmunity (2) . This research topic was conceived to bring together studies that address current challenges and bridge the existing gaps in TRMs biology, including mechanism underlying tissues heterogeneity, interaction between TRMs and other immune cells in controlling pathogenic infections and autoimmune responses, and the development of novel macrophage-targeted therapeutic approaches. The five published articles cover a broad range of topics, including macrophage-mediated immune regulation, disease development, polarization, and emerging therapeutic approaches using both preclinical models and clinical settings. Here, we summarize their key findings, highlighting advances and new insights in TRMs research.
Editorial05 January 2026
Editorial: Sentinels of the immune system: tissue-resident macrophages in the battle against infection and autoimmunityTriggering receptors expressed on myeloid cells 2 (TREM2), an immune receptor expressed on myeloid cells, has garnered considerable attention in recent years due to its role in unique signaling pathways and diverse biological functions, including phagocytosis, lipid metabolism, cell survival, and inflammatory responses. Although TREM2 is expressed in various cell types, such as macrophages, dendritic cells (DCs), osteoclasts, and others, where it exhibits context-dependent functional characteristics, it is mainly expressed in macrophages. Notably, TREM2 is implicated in the development and progression of multiple diseases, playing dual and often opposing roles in noncancerous diseases and cancers. This review aims to highlight the pivotal role of TREM2 in macrophages and immune-related diseases, elucidate its underlying mechanisms of action, explore its potential as a clinical diagnostic and prognostic marker, and propose therapeutic strategies targeting TREM2 based on current clinical trial data, providing comprehensive guidance and references for clinical practice.

